Cyclo Commences Phase 2b Study of Trappsol Cyclo
04 Oct 2022 //
BUSINESSWIRE
Cyclo Therapeutics Announces Positive Feedback from EMA on its for Trappsol
18 May 2020 //
YAHOO
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial
22 Oct 2019 //
BUSINESSWIRE
ZyVersa Th.,` Viewpoint on "Why Kidney Indications Are Coming into Sharp Focus"
14 Oct 2019 //
PR NEWSWIRE
CTD Holdings Announces FDA Approval of US Expanded Access Treatment Program
13 Sep 2019 //
BUSINESSWIRE
Bioavailability enhancement of itraconazole-based solid dispersions
15 Dec 2016 //
PHARMA EXCIPIENTS